New York State Common Retirement Fund
DAWN

New York State Common Retirement Fund’s Day One Biopharmaceuticals DAWN Stock Holding History

New York State Common Retirement Fund’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$530K Buy
24,732
+12,600
+104% +$178K ﹤0.01% 1883
2025
Q4 		$113K Hold
12,132
– – ﹤0.01% 2547
2025
Q3 		$85.5K Hold
12,132
– – ﹤0.01% 2701
2025
Q2 		$78.9K Hold
12,132
– – ﹤0.01% 2809
2025
Q1 		$96.2K Hold
12,132
– – ﹤0.01% 2535
2024
Q4 		$154K Hold
12,132
– – ﹤0.01% 2417
2024
Q3 		$169K Sell
12,132
-7,900
-39% -$113K ﹤0.01% 2380
2024
Q2 		$276K Sell
20,032
-46,196
-70% -$676K ﹤0.01% 2288
2024
Q1 		$1.09M Sell
66,228
-12,071
-15% -$181K ﹤0.01% 1733
2023
Q4 		$1.14M Buy
78,299
+13,294
+20% +$161K ﹤0.01% 1731
2023
Q3 		$798K Sell
65,005
-8,061
-11% -$105K ﹤0.01% 1859
2023
Q2 		$872K Buy
73,066
+18,831
+35% +$246K ﹤0.01% 1840
2023
Q1 		$725K Buy
54,235
+2,422
+5% +$47.3K ﹤0.01% 1983
2022
Q4 		$1.12M Buy
51,813
+23
+0% +$472 ﹤0.01% 1914
2022
Q3 		$1.04M Buy
51,790
+32,322
+166% +$687K ﹤0.01% 1952
2022
Q2 		$348K Buy
19,468
+58
+0.3% +$599 ﹤0.01% 2526
2022
Q1 		$193K Buy
19,410
+11,308
+140% +$149K ﹤0.01% 2832
2021
Q4 		$137K Buy
+8,102
New +$167K ﹤0.01% 2996

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

New York State Common Retirement Fund's DAWN Position: Q1 2026 in Review

New York State Common Retirement Fund increased its Day One Biopharmaceuticals (DAWN) stake by 104% in Q1 2026, buying an estimated $178K and bringing the position to 24,732 shares worth $530K. The position accounts for ﹤0.01% of the portfolio, ranked #1883.

New York State Common Retirement Fund first reported a position in DAWN in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.14M in Q4 2023. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • New York State Common Retirement Fund held 24,732 shares of Day One Biopharmaceuticals worth $530K as of Q1 2026.
  • New York State Common Retirement Fund bought 12,600 Day One Biopharmaceuticals shares in Q1 2026, an estimated $178K.
  • Day One Biopharmaceuticals made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q1 2026, its #1883 holding.
  • New York State Common Retirement Fund first reported a position in Day One Biopharmaceuticals in Q4 2021 and has held it in 18 quarters since.
  • New York State Common Retirement Fund's Day One Biopharmaceuticals position peaked at $1.14M in Q4 2023.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on New York State Common Retirement Fund's 13F filing for Q1 2026, filed 6 May 2026.